Patent · US Active

Isoindoline derivatives

US9975873B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignee

UCB BIOPHARMA SRL · BE

Inventors

David Skolc · Brussels, BE
Ali Ates · Marbais, BE
Eric Jnoff · Brussels, BE
Anne Valade · Brussels, BE
Benoit Mathieu · Brussels, BE
Zara Sands · Brussels, BE

Key dates

Filing date	Oct 6, 2015
Grant date	May 22, 2018
Priority date	—
Expiry date	Oct 6, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/4035
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to isoindoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.